Assessing the impact of MSH3 and MSH6 polymorphisms on lung cancer risk in North Indian patients undergoing platinum chemotherapy through molecular dynamics simulation.
Singh S, Singh N, Gupta PSS, Panda SK, Dhamija I, Nathiya D, Kumar S, Sharma S., Free PMC Article

Attenuated adenomatous polyposis with MSH6 variation: Two case reports.
Ha GW, Lee MR, Ahn AR, Chung MJ, Kim KM., Free PMC Article

TDP43 interacts with MLH1 and MSH6 proteins in a DNA damage-inducible manner.
Provasek VE, Kodavati M, Kim B, Mitra J, Hegde ML., Free PMC Article

Mismatch repair gene MSH6 correlates with the prognosis, immune status and immune checkpoint inhibitors response of endometrial cancer.
Zhou LZ, Xiao HQ, Chen J., Free PMC Article

Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant Carriers.
van der Werf-'t Lam AS, Terlouw D, Tops CM, van Kan MS, van Hest LP, Gille HJP, Duijkers FAM, Wagner A, Eikenboom EL, Letteboer TGW, de Jong MM, Bajwa-Ten Broeke SW, Bleeker FE, Gomez Garcia EB, de Wind N, van Wezel JT, Morreau H, Suerink M, Nielsen M.

Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome-Associated Colorectal Carcinomas.
Helderman NC, Van Der Werf-'t Lam AS, MSH6 TUMOR GROUP, Morreau H, Boot A, Van Wezel T, Nielsen M.

Structural, functional analysis and association of MSH6 rs1800932, rs1042821 polymorphisms with clinical outcome in North Indian lung cancer patients treated with platinum-based doublet chemotherapy.
Singh S, Singh N, Baranwal M, Sharma S.

Novel MSH6 mutation predicted metastasis in eyelid and periocular squamous cell carcinoma.
Luo Y, Rao Y, Gu X, Chai P, Yang Y, Lin J, Xu X, Jia R, Xu S.

Germline variants screening of MLH1, MSH2, MSH6 and PMS2 genes in 64 Algerian Lynch syndrome families: The first nationwide study.
Boumehdi AL, Cherbal F, Khider F, Oukkal M, Mahfouf H, Zebboudj F, Maaoui M.

S6K1 phosphorylates Cdk1 and MSH6 to regulate DNA repair.
Amar-Schwartz A, Ben Hur V, Jbara A, Cohen Y, Barnabas GD, Arbib E, Siegfried Z, Mashahreh B, Hassouna F, Shilo A, Abu-Odeh M, Berger M, Wiener R, Aqeilan R, Geiger T, Karni R., Free PMC Article

DNA methylation status of MutS genes in ameloblastoma.
do Amaral-Silva GK, Pereira TDSF, Rocha AC, Mariz BALA, Prado-Ribeiro AC, Fonseca FP, Gomez RS, Vargas PA.

Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome.
Liu YL, Cadoo KA, Maio A, Patel Z, Kemel Y, Salo-Mullen E, Catchings A, Ranganathan M, Kane S, Soslow R, Ceyhan-Birsoy O, Mandelker D, Carlo MI, Walsh MF, Shia J, Markowitz AJ, Offit K, Stadler ZK, Latham A., Free PMC Article

An integrative pan-cancer analysis reveals the oncogenic role of mutS homolog 6 (MSH6) in human tumors.
Zhan H, Mo F, Xu Q, Wang S, Zhang B, Liu X, Dai M, Liu H., Free PMC Article

Anti-recombination function of MutSα restricts telomere extension by ALT-associated homology-directed repair.
Barroso-González J, García-Expósito L, Galaviz P, Lynskey ML, Allen JAM, Hoang S, Watkins SC, Pickett HA, O'Sullivan RJ., Free PMC Article

Cancer and constitutional Mismatch Repair Deficiency syndrome due to homozygous MSH 6 mutation in children with Café au Lait Spots and review of literature.
Özyörük D, Cabı EÜ, Taçyıldız N, Pınarlı F, Erdoğan AO, Hanalioğlu Ş, Erdem AY, Demir AM.

Quantitative evaluation of MSI testing using NGS detects the imperceptible microsatellite changed caused by MSH6 deficiency.
Yamamoto G, Takenoya T, Takahashi A, Osanai Y, Kakuta M, Tachikawa T, Washio T, Kamiyama M, Shiibashi M, Yamaguchi S, Akagi K.

Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer.
Fujita S, Masago K., Free PMC Article

Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3'UTR of the MSH6 gene.
Cini G, Carnevali I, Sahnane N, Chiaravalli AM, Dell'Elice A, Maestro R, Pin E, Bestetti I, Radovic S, Armelao F, Viel A, Tibiletti MG.

MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer.
Mannucci A, Zuppardo RA, Crippa S, Carrera P, Patricelli MG, Russo Raucci A, Calabrese F, Lazarevic D, Giannese F, Tonon G, Ferrari M, Testoni PA, Cavestro GM.

Associations Between Mutations in MSH6 and PMS2 and Risk of Surveillance-detected Colorectal Cancer.
Lamba M, Wakeman C, Ebel R, Hamilton S, Frampton C, Kiesanowski M, Griffiths B, Keating J, Parry S, Chalmers-Watson T.

Linker domain function predicts pathogenic MLH1 missense variants.
London J, Martín-López J, Yang I, Liu J, Lee JB, Fishel R., Free PMC Article

Methylation patterns in dysplasia in inflammatory bowel disease patients.
Rosa I, Silva P, da Mata S, Magro F, Carneiro F, Peixoto A, Silva M, Sousa HT, Roseira J, Parra J, Barosa R, Vieira A, Brito MJ, Lago P, Coelho A, Moleiro J, Pereira da Silva J, Fonseca R, Albuquerque C, Dias Pereira A, Grupo de Estudos em Doença Inflamatória Intestinal – GEDII.

Cancer-risk by family history and mismatch-repair mutation in Lynch syndrome.
Marques-de-Sá I, Castro R, Pita I, Dinis-Ribeiro M, Brandão C.

Paediatric systemic lupus erythematosus as a manifestation of constitutional mismatch repair deficiency.
Toledano H, Orenstein N, Sofrin E, Ruhrman-Shahar N, Amarilyo G, Basel-Salmon L, Shuldiner AR, Smirin-Yosef P, Aronson M, Al-Tarrah H, Bazak L, Gonzaga-Jauregui C, Tabori U, Wimmer K, Goldberg Y.

Variable Expression of MSH6 in Endometrial Carcinomas With Intact Mismatch Repair and With MLH1 Loss Due to MLH1 Methylation.
Tandon N, Hudgens C, Fellman B, Tetzlaff MT, Broaddus RR., Free PMC Article